Dissecting the Immune Component of Neurologic Disorders: A Grand Challenge for the 21st Century

por Coyle, Patricia Katherine
Publicado 2011

Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives

por Coyle, Patricia K.
Publicado 2017

What Can We Learn from Sex Differences in MS?

por Coyle, Patricia K.
Publicado 2021

A Case Report of Neurosarcoidosis Presenting as a Lymphoma Mimic

por Kaur, Gurcharanjeet, Cameron, Lauren, Syritsyna, Olga, Coyle, Patricia, Kowalska, Agnes
Publicado 2016

Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era

por Coyle, Patricia K., Gocke, Anne, Vignos, Megan, Newsome, Scott D.
Publicado 2021

Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era

por Coyle, Patricia K., Gocke, Anne, Vignos, Megan, Newsome, Scott D.
Publicado 2021

High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis

por Freeman, Léorah, Longbrake, Erin E., Coyle, Patricia K., Hendin, Barry, Vollmer, Timothy
Publicado 2022

Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?

por Vermersch, Patrick, Hobart, Jeremy, Dive-Pouletty, Catherine, Bozzi, Sylvie, Hass, Steven, Coyle, Patricia K
Publicado 2016

The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review

por Rammohan, Kottil, Coyle, Patricia K., Sylvester, Elke, Galazka, Andrew, Dangond, Fernando, Grosso, Megan, Leist, Thomas P.
Publicado 2020

Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS

por Freedman, Mark S., Brod, Staley, Singer, Barry A., Cohen, Bruce A., Hayward, Brooke, Dangond, Fernando, Coyle, Patricia K.
Publicado 2019

Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine Tablets

por Giovannoni, Gavin, Coyle, Patricia K., Vermersch, Patrick, Walker, Bryan, Aldridge, Julie, Nolting, Axel, Galazka, Andrew, Lemieux, Caroline, Leist, Thomas P.
Publicado 2021

Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes

por Coyle, Patricia K, Cohen, Bruce A, Leist, Thomas, Markowitz, Clyde, Oleen-Burkey, MerriKay, Schwartz, Marc, Tullman, Mark J, Zwibel, Howard
Publicado 2014

The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study

por Freedman, Mark S, Leist, Thomas P, Comi, Giancarlo, Cree, Bruce AC, Coyle, Patricia K, Hartung, Hans-Peter, Vermersch, Patrick, Damian, Doris, Dangond, Fernando
Publicado 2017

Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies

por De Stefano, Nicola, Sormani, Maria Pia, Giovannoni, Gavin, Rammohan, Kottil, Leist, Thomas, Coyle, Patricia K, Dangond, Fernando, Keller, Birgit, Alexandri, Nektaria, Galazka, Andrew
Publicado 2021

Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey

por Tumani, Hayrettin, Coyle, Patricia K, Cárcamo, Claudia, Cordioli, Cinzia, López, Pablo A, Peterka, Marek, Ramo-Tello, Cristina, Zuluaga, María I, Koster, Thijs, Vignos, Megan
Publicado 2023

Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study

por Freedman, Mark S, Coyle, Patricia K, Comi, Giancarlo, L Scarberry, Susan, Damian, Doris, Hyvert, Yann, Dangond, Fernando, Galazka, Andrew, Jack, Dominic, Lebson, Lori A, Leist, Thomas P
Publicado 2021

Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis

por Comi, Giancarlo, Freedman, Mark S., Meca-Lallana, José E., Vermersch, Patrick, Kim, Byoung Joon, Parajeles, Alexander, Edwards, Keith R., Gold, Ralf, Korideck, Houari, Chavin, Jeffrey, Poole, Elizabeth M., Coyle, Patricia K.
Publicado 2020

Gray Matter Is Targeted in First-Attack Multiple Sclerosis

por Schutzer, Steven E., Angel, Thomas E., Liu, Tao, Schepmoes, Athena A., Xie, Fang, Bergquist, Jonas, Vécsei, László, Zadori, Denes, Camp, David G., Holland, Bart K., Smith, Richard D., Coyle, Patricia K.
Publicado 2013

Establishing the Proteome of Normal Human Cerebrospinal Fluid

por Schutzer, Steven E., Liu, Tao, Natelson, Benjamin H., Angel, Thomas E., Schepmoes, Athena A., Purvine, Samuel O., Hixson, Kim K., Lipton, Mary S., Camp, David G., Coyle, Patricia K., Smith, Richard D., Bergquist, Jonas
Publicado 2010

Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome

por Schutzer, Steven E., Angel, Thomas E., Liu, Tao, Schepmoes, Athena A., Clauss, Therese R., Adkins, Joshua N., Camp, David G., Holland, Bart K., Bergquist, Jonas, Coyle, Patricia K., Smith, Richard D., Fallon, Brian A., Natelson, Benjamin H.
Publicado 2011